| Literature DB >> 31536593 |
Stephanie J Estes1, Ahmed M Soliman2, Andrew J Epstein3, Julia C Bond3, Keith Gordon2, Stacey A Missmer4,5.
Abstract
INTRODUCTION: Despite guidance towards minimally invasive, outpatient procedures for endometriosis, many patients nonetheless receive inpatient care. Our objective was to assess trends in patient and hospital characteristics, surgical complications and hospital charges for women with an endometriosis-related inpatient admission in the United States.Entities:
Year: 2019 PMID: 31536593 PMCID: PMC6752838 DOI: 10.1371/journal.pone.0222889
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Sample selection protocol.
Sample sizes are based on weighted national estimates; numbers may not add due to rounding.
Patient and hospital characteristics of women with an inpatient admission for endometriosis (ICD-9 code 617.xx) within time-period-defined cohorts.
| Cohort (defined by years) | ||||
|---|---|---|---|---|
| 2006–07 | 2010–11 | 2014–15 | P-Value | |
| Weighted Sample Size | 101,733 | 60,080 | 27,630 | |
| (%) of total cohort | (%) of total cohort | (%) of total cohort | ||
| Variable | ||||
| Age | ||||
| 18–29 Years | 13.4% | 14.2% | 14.2% | 0.03 |
| 30–39 Years | 40.4% | 41.6% | 41.5% | |
| 40–49 Years | 46.1% | 44.2% | 44.3% | |
| Payer Type | ||||
| Private | 79.3% | 71.8% | 66.1% | <0.001 |
| Medicaid | 10.7% | 15.6% | 22.0% | |
| Uninsured | 3.3% | 4.7% | 4.3% | |
| Medicare and Other | 6.5% | 7.7% | 7.3% | |
| Missing | 0.2% | 0.2% | 0.2% | |
| Elixhauser Comorbidity | ||||
| Zero | 59.9% | 53.8% | 48.8% | <0.001 |
| One | 26.0% | 27.2% | 28.4% | |
| Two | 9.9% | 12.2% | 13.9% | |
| Three or More | 4.2% | 6.8% | 8.9% | |
| National Quartile of ZIP Code-level Median Household Income | ||||
| First | 21.4% | 22.7% | 26.6% | 0.005 |
| Second | 26.7% | 24.8% | 25.9% | |
| Third | 26.4% | 27.8% | 24.6% | |
| Fourth | 23.6% | 23.0% | 21.0% | |
| Missing | 1.9% | 1.7% | 1.8% | |
| Race/Ethnicity | ||||
| White Non-Hispanic | 50.5% | 60.5% | 57.7% | <0.001 |
| Black Non-Hispanic | 6.2% | 10.1% | 13.8% | |
| Hispanic | 7.3% | 10.6% | 14.7% | |
| Other Non-Hispanic | 4.5% | 6.9% | 8.7% | |
| Missing/Not Reported | 31.5% | 11.9% | 5.1% | |
| Hospital Census Region | ||||
| Northeast | 13.5% | 14.8% | 17.3% | 0.06 |
| Midwest | 25.8% | 23.1% | 21.6% | |
| South | 38.7% | 37.8% | 37.4% | |
| West | 22.0% | 24.3% | 23.8% | |
| Hospital Bed Size Category | ||||
| Small | 13.8% | 11.3% | 16.9% | <0.001 |
| Medium | 25.0% | 25.8% | 30.7% | |
| Large | 61.1% | 61.7% | 52.4% | |
| Missing | 0.1% | 1.2% | 0.0% | |
| Hospital Location/Teaching Category | ||||
| Rural | 13.1% | 13.1% | 11.1% | <0.001 |
| Urban-NonTeaching | 46.2% | 42.7% | 25.2% | |
| Urban-Teaching | 40.6% | 43.0% | 63.7% | |
| Missing | 0.1% | 1.2% | 0.0% | |
Abbreviation: ICD-9: International Classification of Diseases, 9th edition
* Data for 2015 cover Q1-Q3 only.
† P-values are from Pearson chi-squared tests that account for survey design.
‡ Weighted counts are nationally representative.
Elixhauser comorbidities are based on a roster of 29 comorbidities using ICD-9 diagnosis codes.23
The first quartile corresponds to ZIP Codes with median household income below the 25th percentile; the fourth corresponds to ZIP Codes above the 75th percentile.
¶ The HCUP NIS combines race and Hispanic ethnicity into a single measure.
Hospital bed-size categories were defined differently based on hospital geographic location, urban/rural, and teaching/non-teaching designation (see: https://www.hcup-us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp).
Fig 2Nationally representative endometriosis inpatient admission rates and total inpatient admissions trends, 2006–2015.
Bars represent the annual endometriosis-related inpatient admission rate per 100,000; solid line represents total inpatient admissions in millions.
Trends in the prevalence of comorbidities among women with an inpatient admission for endometriosis (ICD-9 code 617.xx) within time-period-defined cohorts.
| Cohort (defined by years) | |||||
|---|---|---|---|---|---|
| 2006–07 | 2010–11 | 2014–15 | P-Value for 2006–07 vs 2010–11 vs 2014–15 | P-Value for 2006–07 vs 2014–15 | |
| Weighted Sample Size | 101,733 | 60,080 | 27,630 | ||
| AHRQ Elixhauser Comorbidities | (%) of total cohort | (%) of total cohort | (%) of total cohort | ||
| Congestive heart failure | 0.1% | 0.1% | 0.3% | 0.009 | 0.002 |
| Valvular disease | 1.9% | 1.3% | 0.9% | <0.001 | <0.001 |
| Pulmonary circulation disorders | 0.1% | 0.2% | 0.2% | 0.41 | 0.30 |
| Peripheral vascular disorders | 0.1% | 0.1% | 0.2% | 0.14 | 0.08 |
| Hypertension | 10.6% | 12.5% | 14.7% | <0.001 | <0.001 |
| Paralysis | 0.1% | 0.2% | 0.2% | 0.61 | 0.70 |
| Other neurological disorders | 1.4% | 1.8% | 2.4% | <0.001 | <0.001 |
| Chronic pulmonary disease | 8.1% | 9.6% | 10.3% | <0.001 | <0.001 |
| Diabetes, uncomplicated | 3.2% | 4.0% | 4.7% | <0.001 | <0.001 |
| Diabetes with chronic complications | 0.1% | 0.2% | 0.3% | 0.03 | 0.010 |
| Hypothyroidism | 4.9% | 5.9% | 6.4% | <0.001 | <0.001 |
| Renal failure | 0.2% | 0.2% | 0.5% | <0.001 | <0.001 |
| Liver disease | 0.3% | 0.4% | 0.6% | <0.001 | <0.001 |
| Peptic ulcer disease excluding bleeding | 0.004% | 0.02% | 0% | 0.35 | 0.60 |
| Acquired immune deficiency syndrome | 0.02% | 0.04% | 0.02% | 0.43 | 0.97 |
| Lymphoma | 0.05% | 0.01% | 0.04% | 0.19 | 0.77 |
| Metastatic cancer | 0.04% | 0.03% | 0.1% | 0.79 | 0.55 |
| Solid tumor without metastasis | 0.2% | 0.2% | 0.2% | 0.57 | 0.33 |
| Rheumatoid arthritis/collagen vascular diseases | 0.9% | 1.2% | 1.3% | 0.008 | 0.010 |
| Coagulopathy | 0.4% | 0.5% | 0.9% | <0.001 | <0.001 |
| Obesity | 6.10% | 9.4% | 13.3% | <0.001 | <0.001 |
| Weight loss | 0.1% | 0.3% | 0.5% | <0.001 | <0.001 |
| Fluid and electrolyte disorders | 1.8% | 3.0% | 3.6% | <0.001 | <0.001 |
| Chronic blood loss anemia | 3.3% | 2.1% | 2.2% | <0.001 | <0.001 |
| Deficiency anemias | 6.2% | 8.2% | 10.4% | <0.001 | <0.001 |
| Alcohol abuse | 0.1% | 0.3% | 0.3% | 0.005 | 0.005 |
| Drug abuse | 0.5% | 1.0% | 1.3% | <0.001 | <0.001 |
| Psychoses | 1.5% | 2.2% | 2.6% | <0.001 | <0.001 |
| Depression | 7.3% | 10.2% | 9.9% | <0.001 | <0.001 |
Abbreviations: ICD-9: International Classification of Diseases, 9th edition; AHRQ: Agency for Healthcare Research and Quality
* Data for 2015 cover Q1-Q3 only.
† P-values are from ANOVA tests of equality that accounted for survey design.
‡ Weighted counts are nationally representative.
Elixhauser comorbidities were constructed using ICD-9 diagnosis codes.
Trends in surgical procedures reported in inpatients visits for endometriosis across cohorts.
| Cohort (defined by years) | |||||
|---|---|---|---|---|---|
| Outcome | 2006–07 | 2010–11 | 2014–15 | P-Value for 2006–07 vs 2010–11 vs 2014–15 | P-Value for 2006–07 vs 2014–15 |
| Weighted Sample Size | 101,733 | 60,080 | 27,630 | ||
| Surgical Procedure | (%) of total cohort | (%) of total cohort | (%) of total cohort | ||
| Hysterectomy | 78.2% | 74.1% | 67.4% | <0.001 | <0.001 |
| Bladder Intervention | 0.4% | 0.5% | 0.4% | 0.98 | 0.93 |
| Laparoscopy | 2.5% | 2.4% | 3.0% | 0.06 | 0.04 |
| Laparotomy | 11.2% | 11.0% | 13.1% | 0.004 | 0.002 |
| Oophorectomy | 62.9% | 60.1% | 58.3% | <0.001 | <0.001 |
| Other Excision/Ablation | 8.2% | 10.2% | 11.9% | <0.001 | <0.001 |
| Salpingectomy | 1.0% | 1.5% | 2.7% | <0.001 | <0.001 |
| Any of the Above Surgeries | 95.9% | 93.9% | 91.1% | <0.001 | <0.001 |
* Data for 2015 cover Q1-Q3 only.
† P-values are from ANOVA tests of equality that accounted for survey design.
‡ Weighted counts are nationally representative.
These seven categories of surgical procedures were selected as the most common surgical procedure types used for endometriosis management.
Trends in surgical complications, total charges and inpatient length of stay across cohorts.
| Cohort (defined by years) | ||||||
|---|---|---|---|---|---|---|
| Outcome | 2006–07 | 2010–11 | 2014–15 | P-Value for 2006–07 vs 2010–11 vs 2014–15 | P-Value for 2006–07 vs 2014–15 | |
| Weighted Sample Size | 101,733 | 60,080 | 27,630 | |||
| (%) of total cohort | (%) of total cohort | (%) of total cohort | ||||
| Prevalence of Complications by Surgical Procedure | ||||||
| Hysterectomy | 12.4% | 13.3% | 15.3% | <0.001 | <0.001 | |
| Bladder Intervention | 12.1% | 10.2% | 17.4% | 0.61 | 0.47 | |
| Laparoscopy | 15.2% | 17.6% | 24.0% | 0.053 | 0.016 | |
| Laparotomy | 15.3% | 16.8% | 19.9% | 0.02 | 0.005 | |
| Oophorectomy | 13.7% | 14.3% | 16.6% | 0.001 | <0.001 | |
| Other Excision/Ablation | 17.0% | 16.8% | 18.7% | 0.59 | 0.38 | |
| Salpingectomy | 17.6% | 16.1% | 12.8% | 0.46 | 0.21 | |
| Any of the Above Surgeries | 12.9% | 13.8% | 16.0% | <0.001 | <0.001 | |
| Mean Length of Stay (Days) | 2.4 | 2.3 | 2.6 | <0.001 | 0.013 | |
| Mean Total Charges per Stay (2015 USD) | 22,642 | 30,977 | 39,662 | <0.001 | <0.001 | |
Abbreviation: USD: United States Dollars
* Data for 2015 covers Q1-Q3 only.
† P-values are from ANOVA tests of equality that accounted for survey design.
‡ Weighted counts are nationally representative.
These seven categories of surgical procedures were selected as the most common surgical procedure types used for endometriosis management.